These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12933660)

  • 1. A constitutively active somatic mutation of the human lutropin receptor found in Leydig cell tumors activates the same families of G proteins as germ line mutations associated with Leydig cell hyperplasia.
    Hirakawa T; Ascoli M
    Endocrinology; 2003 Sep; 144(9):3872-8. PubMed ID: 12933660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor.
    Min L; Ascoli M
    Mol Endocrinol; 2000 Nov; 14(11):1797-810. PubMed ID: 11075813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of Gs-coupled receptor signaling by constitutively active mutants of the human lutropin/choriogonadotropin receptor.
    Shinozaki H; Butnev V; Tao YX; Ang KL; Conti M; Segaloff DL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1194-204. PubMed ID: 12629106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.
    Latronico AC; Shinozaki H; Guerra G; Pereira MA; Lemos Marini SH; Baptista MT; Arnhold IJ; Fanelli F; Mendonca BB; Segaloff DL
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4799-805. PubMed ID: 11134146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty.
    Latronico AC; Abell AN; Arnhold IJ; Liu X; Lins TS; Brito VN; Billerbeck AE; Segaloff DL; Mendonca BB
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2435-40. PubMed ID: 9661624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation.
    Galet C; Ascoli M
    Mol Endocrinol; 2006 Nov; 20(11):2931-45. PubMed ID: 16803865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the LH receptor gene in Leydig cell adenoma and hyperplasia and functional and biochemical studies of activating mutations of the LH receptor gene.
    Boot AM; Lumbroso S; Verhoef-Post M; Richter-Unruh A; Looijenga LH; Funaro A; Beishuizen A; van Marle A; Drop SL; Themmen AP
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1197-205. PubMed ID: 21490077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs.
    Abell AN; McCormick DJ; Segaloff DL
    Mol Endocrinol; 1998 Dec; 12(12):1857-69. PubMed ID: 9849960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): a novel experimental paradigm to study the functional properties of the hLHR.
    Hirakawa T; Galet C; Ascoli M
    Endocrinology; 2002 Mar; 143(3):1026-35. PubMed ID: 11861529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty.
    Laue L; Wu SM; Kudo M; Hsueh AJ; Cutler GB; Jelly DH; Diamond FB; Chan WY
    Biochem Mol Med; 1996 Aug; 58(2):192-8. PubMed ID: 8812739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.
    Yano K; Saji M; Hidaka A; Moriya N; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1162-8. PubMed ID: 7714085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor.
    Latronico AC; Segaloff DL
    Mol Cell Endocrinol; 2007 Jan; 260-262():287-93. PubMed ID: 17055147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations.
    Zhang M; Tao YX; Ryan GL; Feng X; Fanelli F; Segaloff DL
    J Biol Chem; 2007 Aug; 282(35):25527-39. PubMed ID: 17609213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty.
    Shenker A
    Recept Channels; 2002; 8(1):3-18. PubMed ID: 12408104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.
    Shenker A; Laue L; Kosugi S; Merendino JJ; Minegishi T; Cutler GB
    Nature; 1993 Oct; 365(6447):652-4. PubMed ID: 7692306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases.
    Yano K; Hidaka A; Saji M; Polymeropoulos MH; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1818-23. PubMed ID: 7527413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
    Shinozaki H; Fanelli F; Liu X; Jaquette J; Nakamura K; Segaloff DL
    Mol Endocrinol; 2001 Jun; 15(6):972-84. PubMed ID: 11376115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of Galpha(z)-specific sequence at the carboxyl terminus increases the promiscuity of galpha(16) toward G(i)-coupled receptors.
    Mody SM; Ho MK; Joshi SA; Wong YH
    Mol Pharmacol; 2000 Jan; 57(1):13-23. PubMed ID: 10617674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of arrestin-3 with the human lutropin/choriogonadotropin receptor depends mostly on receptor activation rather than on receptor phosphorylation.
    Min L; Galet C; Ascoli M
    J Biol Chem; 2002 Jan; 277(1):702-10. PubMed ID: 11696538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precocious puberty and Leydig cell hyperplasia in male mice with a gain of function mutation in the LH receptor gene.
    McGee SR; Narayan P
    Endocrinology; 2013 Oct; 154(10):3900-13. PubMed ID: 23861372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.